Bexsero.com


Keyword Suggestion

Bexsero
Bexsero vaccine
Bexsero dosing schedule
Bexsero vis
Bexsero dosing
Bexsero pi
Bexsero schedule
Bexsero age
Bexsero cpt code
Bexsero package insert
Bexsero vs trumenba
Bexsero cdc
Bexsero side effects
Bexsero vs menveo
Bexsero spc
Bexsero vaccine schedule
Bexsero prescribing information
Bexsero impfung
Bexsero schema
Bexsero vidal



Domain Informations

Bexsero.com lookup results from whois.safenames.net server:
  • Domain created: 2009-11-11T20:42:09Z
  • Domain updated: 2023-11-12T00:59:19Z
  • Domain expires: 2024-11-11T20:42:09Z 0 Years, 195 Days left
  • Website age: 14 Years, 170 Days
  • Registrar Domain ID: 1575403592_DOMAIN_COM-VRSN
  • Registrar Url: http://www.safenames.net
  • Registrar WHOIS Server: whois.safenames.net
  • Registrar Abuse Contact Email: [email protected]
  • Registrar Abuse Contact Phone: +44.1908200022
  • Name server:
    • NS-1070.AWSDNS-05.ORG
    • NS-1601.AWSDNS-08.CO.UK
    • NS-87.AWSDNS-10.COM
    • NS-999.AWSDNS-60.NET

Network
  • inetnum : 34.64.0.0 - 34.127.255.255
  • name : GOOGL-2
  • handle : NET-34-64-0-0-1
  • status : Direct Allocation
  • created : 2006-09-29
  • changed : 2019-11-01
  • desc : *** The IP addresses under this Org-ID are in use by Google Cloud customers ***,Direct all copyright and legal complaints to,https://support.google.com/legal/go/report,Direct all spam and abuse complaints to,https://support.google.com/code/go/gce_abuse_report,For fastest response, use the relevant forms above.,Complaints can also be sent to the GC Abuse desk,([email protected]),but may have longer turnaround times.,Complaints sent to any other POC will be ignored.
Owner
  • organization : Google LLC
  • handle : GOOGL-2
  • address : Array,Mountain View,CA,94043,US
Abuse
Technical support
Domain Provider Number Of Domains
godaddy.com 286730
namecheap.com 101387
networksolutions.com 69118
tucows.com 52617
publicdomainregistry.com 39120
whois.godaddy.com 32793
enomdomains.com 23825
namesilo.com 21429
domains.google.com 21384
cloudflare.com 20573
gmo.jp 18110
name.com 17601
fastdomain.com 14708
register.com 13495
net.cn 12481
ionos.com 12416
ovh.com 12416
gandi.net 12305
registrar.amazon.com 12111


Host Informations

  • IP address: 34.107.225.66
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Check all domain's dns records


See Web Sites Hosted on 34.107.225.66

Fetching Web Sites Hosted


Site Inspections


Port Scanner (IP: 34.107.225.66)

 › Ftp: 21
 › Ssh: 22
 › Telnet: 23
 › Smtp: 25
 › Dns: 53
 › Http: 80
 › Pop3: 110
 › Portmapper, rpcbind: 111
 › Microsoft RPC services: 135
 › Netbios: 139
 › Imap: 143
 › Ldap: 389
 › Https: 443
 › SMB directly over IP: 445
 › Msa-outlook: 587
 › IIS, NFS, or listener RFS remote_file_sharing: 1025
 › Lotus notes: 1352
 › Sql server: 1433
 › Point-to-point tunnelling protocol: 1723
 › My sql: 3306
 › Remote desktop: 3389
 › Session Initiation Protocol (SIP): 5060
 › Virtual Network Computer display: 5900
 › X Window server: 6001
 › Webcache: 8080


Spam Check (IP: 34.107.225.66)

 › Dnsbl-1.uceprotect.net:
 › Dnsbl-2.uceprotect.net:
 › Dnsbl-3.uceprotect.net:
 › Dnsbl.dronebl.org:
 › Dnsbl.sorbs.net:
 › Spam.dnsbl.sorbs.net:
 › Bl.spamcop.net:
 › Recent.dnsbl.sorbs.net:
 › All.spamrats.com:
 › B.barracudacentral.org:
 › Bl.blocklist.de:
 › Bl.emailbasura.org:
 › Bl.mailspike.org:
 › Bl.spamcop.net:
 › Cblplus.anti-spam.org.cn:
 › Dnsbl.anticaptcha.net:
 › Ip.v4bl.org:
 › Fnrbl.fast.net:
 › Dnsrbl.swinog.ch:
 › Mail-abuse.blacklist.jippg.org:
 › Singlebl.spamgrouper.com:
 › Spam.abuse.ch:
 › Spamsources.fabel.dk:
 › Virbl.dnsbl.bit.nl:
 › Cbl.abuseat.org:
 › Dnsbl.justspam.org:
 › Zen.spamhaus.org:


Email address with bexsero.com

Found 0 emails of this domain

Recent Searched Sites

Ranjoganj.ir (45 seconds ago) / IR

Koreader.rocks (17 seconds ago) / US

Neginshargh.com (1 seconds ago) / IR

Talentry.com (23 seconds ago) / CA

Csc.gov.au (11 seconds ago) / US

Bexsero.com (0 seconds ago) / US

Blog6.info (29 seconds ago) / TW

Thundershare.net (4 seconds ago) / US

Gracechurch.us (15 seconds ago) / US

Weather.meteostar.com (1 mins ago) / US

Liveinlog.com (11 seconds ago) / US

Nimiti.org (37 seconds ago) / US

Kencolemusic.com (2 seconds ago) / US

Ahvaz.iau.ir (4 seconds ago) / IR

Offer.buybyecritter.com (0 seconds ago) / US

Farmingtonfamilydental.com (7 seconds ago) / US

Psyop.com (3 seconds ago) / US

M.huarenstore.com (9 seconds ago) / US

Mediniqhealthcare.com (33 seconds ago) / US

Alcoholism-addiction.conferenceseries.com (7 seconds ago) / US

Websites Listing

We found Websites Listing below when search with bexsero.com on Search Engine

BEXSERO CANADA - Meningitis B vaccination and …

BEXSERO multicomponent meningococcal B vaccine (recombinant, adsorbed) is a vaccine for the prevention of meningococcal disease caused by Neisseria meningitidis group B bacteria in individuals from 2 months through 25 years of age. BEXSERO is not expected to protect against all circulating meningococcal serogroup B strains and does not offer protection against strains …

Bexsero.ca

BEXSERO CANADA – Dose Reminder

BEXSERO multicomponent meningococcal B vaccine (recombinant, adsorbed) is a vaccine for the prevention of meningococcal disease caused by Neisseria meningitidis group B bacteria in individuals from 2 months through 25 years of age. BEXSERO is not expected to protect against all circulating meningococcal serogroup B strains and does not offer protection against strains …

Bexsero.ca

BEXSERO | GSK Canada

Group 21. Created with Sketch. In all of our interactions with HCPs we aim to be transparent about our work, operate with integrity, and always put our patients first. ×. Where we operate. You are currently visiting our Canada website. Global https://www.gsk.com. Africa. Group 21.

Ca.gsk.com

Bexsero - FDA prescribing information, side effects and uses

2022-01-01  · Bexsero is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Bexsero is approved for use in individuals aged 10 through 25 years. Approval of Bexsero is based on demonstration of immune response, as measured by serum bactericidal activity against three serogroup B strains ...

Drugs.com

Dosing and administration - GSKpro

Recommended dosing schedule for BEXSERO 1. * The need for, and timing of further doses has not yet been determined. BEXSERO should be given by deep intramuscular injection, preferably in the anterolateral aspect of the thigh in infants or in the deltoid muscle region of the upper arm in older subjects. The vaccine must not be mixed with other ...

Gskpro.com

Resources - GSKpro

BEXSERO resources. If you would like to receive printed copies of any of these resources for your practice, please contact your GSK Customer Response Center at 1-800-387-7374.

Gskpro.com

Bexsero Product Monograph - GSK

BEXSERO, Multicomponent Meningococcal B Vaccine Page 8 of 54 acetaminophen at the time of, and closely after vaccination, can reduce the incidence and intensity of post-vaccination febrile reactions in infants and children (less than 2 years of age). Administration of BEXSERO should be postponed in individuals suffering from an acute severe febrile illness. However, the presence …

Ca.gsk.com

Meningococcal B Vaccine (Bexsero®): Information for high risk ...

(4CMenB or Bexsero ®) to individuals with high risk conditions from 2 months through 17 years of age with the following conditions: a. Individuals with functional or anatomic asplenia b. Individuals with complement, properdin, factor D or primary antibody deficiencies c. Cochlear implant recipients (pre/post implants) d. Individuals with ...

Health.gov.on.ca

Meningococcal B Vaccine (Bexsero®): Q&A for health care providers

About the publicly funded M eningococcal B Vaccine (Bexsero ®) In December 2013, Health Canada approved Bexsero ®, a novel multicomponent meningococcal B vaccine (4CMenB), manufactured by Novartis. Bexsero ® protects against meningococcal serogroup B disease, and has been authorized for use in individuals 2 months through 17 years of age.

Health.gov.on.ca

必思諾 B 型腦膜炎雙球菌疫苗 - GSK

Bexsero: 的核准是基於施打疫苗後針對特殊菌株的免疫反應(serum bactericidal activity),其對於其他多種不同菌株的B 型奈瑟氏腦膜炎雙球菌的疫苗效果尚未確 認,施打Bexsero 應考量不同區域流行的B 型奈瑟氏腦膜炎雙球菌菌株。Bexsero 應遵照官方建議使用。 劑量與用法

Tw.gsk.com

Dosing | BEXSERO (Meningococcal Group B Vaccine) Info for HCPs

BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO is approved for use in individuals aged 10 through 25 years.. Approval of BEXSERO is based on demonstration of immune response, as measured by serum bactericidal activity against three serogroup B strains representative of prevalent …

Bexserohcp.com

BEXSERO - MesVaccins.net

BEXSERO. Vaccin disponible. La primovaccination des nourrissons âgés de 2 à 5 mois peut être réalisée avec deux doses espacées de deux mois au …

Mesvaccins.net

Bexsero®: First Vaccine to Prevent Meningococcal Serogroup B …

2014-02-26  · Bexsero ® is the result of more than 40 years of pioneering vaccine research. 6 The tolerability profile and immunogenicity of Bexsero ® have been established through a comprehensive clinical ...

Newswire.ca

BEXSERO | FDA

2022-01-07  · BEXSERO. STN: BL 125546. Proper Name: Meningococcal Group B Vaccine. Trade Name: BEXSERO. Manufacture: GlaxoSmithKline. Indication: Active immunization to prevent invasive disease caused by ...

Fda.gov

Bexsero (Meningococcal Group B Vaccine): Uses, Dosage, Side

2022-05-11  · INDICATIONS. BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO is approved for use in individuals 10 through 25 years of age.. Approval of BEXSERO is based on demonstration of immune response, as measured by serum bactericidal activity against three serogroup B …

Rxlist.com

Bexsero :: WoWProgress - World of Warcraft Rankings

Detailed character history for Bexsero, EU-Taerar: loot history, guilds, build changes

Wowprogress.com

Bexsero - Impfstoff - Kinderarzt.net

Preis inkl Impfgebühr in unserer Kinderarztpraxis: 130 Euro. 1. Bezeichnung. Bexsero Injektionssuspension in einer Fertigspritze, Impfstoff gegen Meningokokken der Gruppe B (rDNA, Komponenten, adsorbiert) 2. Zusammensetzung von Bexsero. Eine Dosis (0,5 ml) enthält: Rekombinantes NHBA-Fusionsprotein von Neisseria meningitidis der Gruppe B 1,2,3.

Kinderarzt.net

Package Insert - BEXSERO (Meningococcal Group B Vaccine)

BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO is approvedfor use in i ndividuals 10 through 25 years of age. (1) Approval of BEXSERO is based on demonstration of immune response, as measured by serum bactericidal activity against three serogroup B strains representative of …

Pubmedinfo.org

Bexsero | Immunisation Advisory Centre

Bexsero ®, a multicomponent recombinant vaccine against meningococcal group B disease only is available in New Zealand. Bexsero was first approved for use in Europe in 2013, since then the vaccine has been approved for use in more than 40 countries including Australia, the United Kingdom and the United States. Conjugated meningococcal vaccines that protect against …

Immune.org.nz

Bexsero - Pediatrics - Jul Display Banners HCP Wallboard Extension ...

Bexsero – Pediatrics – Jul Display Banners HCP Wallboard Extension – 22743. Childhood Bedtime Before 9:00pm Cuts Overweight & Obesity Risk by One-Third. Jun 1, 2022 “ Previous research has shown that longer sleep duration is tied to lower adiposity and weight status in youth,” explains Paul J. Collings, PhD. “Parameters such as bedtimes and sleep quality may …

Physiciansweekly.com


Domains Expiration Date Updated

Site Provider Expiration Date
kokosrestaurant.com godaddy.com -2 Years, -30 Days
dusdata.com godaddy.com -1 Years, -121 Days
forbiddenteens1.top namesilo.com -1 Years, -152 Days
bemaziesconsult.com ownregistrar.com -2 Years, -43 Days
keyanlib.com west.cn 296 Days
fyzbw.com enomdomains.com -1 Years, -74 Days
osx9.com namesilo.com -1 Years, -330 Days
seebeyondmag.com namecheap.com -1 Years, -46 Days
acpsm.org porkbun.com -1 Years, -335 Days
effikos.com enomdomains.com -2 Years, -51 Days

    Browser All

    .com4.3M domains   

    .org1M domains   

    .edu40.9K domains   

    .net608.3K domains   

    .gov15.9K domains   

    .us31.2K domains   

    .ca44.9K domains   

    .de556.9K domains   

    .uk465.9K domains   

    .it34.5K domains   

    .au46.4K domains   

    .co33.9K domains   

    .biz13.9K domains   

    .info36.6K domains   

    .fr37.2K domains   

    .eu24.6K domains   

    .ru193.8K domains   

    .ph5.6K domains   

    .in54.2K domains   

    .vn18.8K domains   

    .cn40.1K domains   

    .ro19.3K domains   

    .ch11.6K domains   

    .at10.2K domains   

    Browser All